|
Multiple Sclerosis/ Demyelinating Disease
Contributing journals to this collection:
JAMA & Archives Journals
Citations 171-180 of 370 total displayed.
- Original Contributions
Effects of Interferon Beta-1b on Black Holes in Multiple Sclerosis Over a 6-Year Period With Monthly Evaluations
- Francesca Bagnato; Shiva Gupta; Nancy D. Richert; Roger D. Stone; Joan M. Ohayon; Joseph A. Frank; Henry F. McFarland
Arch Neurol 2005; 62: 1684-1688.
[Abstract]
[Full text]
[PDF]
- Neurological Reviews
Therapeutic Considerations for Disease Progression in Multiple Sclerosis: Evidence, Experience, and Future Expectations
- Elliot M. Frohman; Olaf Stüve; Eva Havrdova; John Corboy; Anat Achiron; Robert Zivadinov; Per Soelberg Sorensen; J. Theodore Phillips; Brian Weinshenker; Kathleen Hawker; Hans-Peter Hartung; Lawrence Steinman; Scott Zamvil; Bruce A. C. Cree; Stephen Hauser; Howard Weiner; Michael K. Racke; Massimo Filippi
Arch Neurol 2005; 62: 1519-1530.
[Abstract]
[Full text]
[PDF]
- Observations
Clinical Stabilization and Effective B-Lymphocyte Depletion in the Cerebrospinal Fluid and Peripheral Blood of a Patient With Fulminant Relapsing-Remitting Multiple Sclerosis
- Olaf Stüve; Sabine Cepok; Birte Elias; Andreas Saleh; Hans-Peter Hartung; Bernhard Hemmer; Bernd C. Kieseier
Arch Neurol 2005; 62: 1620-1623.
[Abstract]
[Full text]
[PDF]
- Correspondence
Effective Suppression of Cerebrospinal Fluid B Cells by Rituximab and Cyclophosphamide in Progressive Multiple Sclerosis
- Hela-F Petereit; Andrea Rubbert
Arch Neurol 2005; 62: 1641-b-1642-b.
[Extract]
[Full text]
[PDF]
- Correspondence
Effective Suppression of Cerebrospinal Fluid B Cells by Rituximab and Cyclophosphamide in Progressive Multiple SclerosisReply
- Nancy L. Monson
Arch Neurol 2005; 62: 1642.
[Extract]
[Full text]
[PDF]
- The World in Medicine
Birth Order and MS
- Joan Stephenson
JAMA 2005; 294: 1331-c.
[Extract]
[Full text]
[PDF]
- Original Contributions
Effects of Interferon Beta-1b on Black Holes in Multiple Sclerosis Over a 6-Year Period With Monthly Evaluations
- Francesca Bagnato; Shiva Gupta; Nancy D. Richert; Roger D. Stone; Joan M. Ohayon; Joseph A. Frank; Henry F. McFarland
Arch Neurol 62.11.noc40499.
[Abstract]
[Full text]
[PDF]
- Neurological Reviews
Characterizing the Mechanisms of Progression in Multiple Sclerosis: Evidence and New Hypotheses for Future Directions
- E. M. Frohman; M. Filippi; O. Stuve; S. G. Waxman; J. Corboy; J. T. Phillips; C. Lucchinetti; J. Wilken; N. Karandikar; B. Hemmer; N. Monson; J. De Keyser; H. Hartung; L. Steinman; J. R. Oksenberg; B. A. C. Cree; S. Hauser; M. K. Racke
Arch Neurol 2005; 62: 1345-1356.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Recent Use of Oral Contraceptives and the Risk of Multiple Sclerosis
- Álvaro Alonso; Susan S. Jick; Michael J. Olek; Alberto Ascherio; Hershel Jick; Miguel A. Hernán
Arch Neurol 2005; 62: 1362-1365.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Prediction of Longitudinal Brain Atrophy in Multiple Sclerosis by Gray Matter Magnetic Resonance Imaging T2 Hypointensity
- Robert A. Bermel; Srinivas R. Puli; Richard A. Rudick; Bianca Weinstock-Guttman; Elizabeth Fisher; Frederick E. Munschauer III; Rohit Bakshi
Arch Neurol 2005; 62: 1371-1376.
[Abstract]
[Full text]
[PDF]
|
Advertisement


|
|
|